Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies

por Estes, C., Abdel‐Kareem, M., Abdel‐Razek, W., Abdel‐Sameea, E., Abuzeid, M., Gomaa, A., Osman, W., Razavi, H., Zaghla, H., Waked, I.
Publicado 2015

The new paradigm of hepatitis C therapy: integration of oral therapies into best practices

por Afdhal, N H, Zeuzem, S, Schooley, R T, Thomas, D L, Ward, J W, Litwin, A H, Razavi, H, Castera, L, Poynard, T, Muir, A, Mehta, S H, Dee, L, Graham, C, Church, D R, Talal, A H, Sulkowski, M S, Jacobson, I M for the New Paradigm of HCV Therapy Meeting Participants
Publicado 2013